Prenetics Global: Is Undervalued, Supported By Portfolio Optimization In 2026 (Buy)
Source: SeekingAlpha
2026-01-17 00:58:28 ET
International health science company, Prenetics Global Limited ( PRE ), recently announced its decision to pause the purchase of Bitcoins and instead reallocate its capital towards the production and sale of its premium supplement, IM8. The stock is up 172% (YoY) and is trading just 17% below its 52-week high of $18.48. Still, I believe the stock is undervalued, and the management’s focus on raising revenue guidance through 2026 is a strategic move regarding its capital allocation....
Read the full article on Seeking Alpha
For further details see:
Prenetics Global: Is Undervalued, Supported By Portfolio Optimization In 2026 (Buy)
Nu Skin Enterprises Inc.
NASDAQ: NUS
NUS Trading
3.32% G/L:
$7.47 Last:
117,789 Volume:
$7.39 Open:
NUS Latest News
February 13, 2026 09:43:00 am
Stonegate Capital Partners Updates Coverage on NU Skin Enterprises Inc. (NUS) 2025 Q4
February 12, 2026 04:06:00 pm
Nu Skin Enterprises Reports Fourth Quarter and Full-year 2025 Results Within Guidance
NUS Stock Data
$494,082,020
47,775,074
0.8%
61
N/A
Consumer Products - Healthcare
Consumer Staples
US
Provo
